Live
FierceBiotechFrom drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’Lonza NewsBMS Licenses SYNtecan Linker-Payload Platform from Lonza - Contract PharmaEndpoints NewsAtara, Pierre Fabre's cell therapy to get another shot at FDA approvalFierceBiotechInsulet boosts guidance in Q1 update as it grapples with recall sagaPharmaVoiceLilly, Gilead lead pharma’s M&A boomLabiotechThe rise of trispecific antibodies: Biopharma’s next big bet after bispecificsEndpoints NewsPennsylvania sues AI chatbot company for posing as a licensed doctorNovo NordiskNovo Nordisk faces competition from Canada compounders - medwatch.comEndpoints NewsAngelini fortifies neurology portfolio with $4.1B buyout of Catalyst PharmaEli LillyPharma Pulse: GLP-1 Momentum Builds While Lilly Expands Genetic Medicine Manufacturing - Pharmaceutical CommerceSiemens HealthineersWeak Diagnostics segment weighs heavily on Siemens Healthineers - marketscreener.com

Archives

Récent Plus ancien Effacer
@Illumina
Total 394
Source Illumina
Recherche --